116 related articles for article (PubMed ID: 33334546)
1. Current role of carbamazepine and oxcarbazepine in the management of epilepsy.
Beydoun A; DuPont S; Zhou D; Matta M; Nagire V; Lagae L
Seizure; 2020 Dec; 83():251-263. PubMed ID: 33334546
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of oxcarbazepine in the treatment of focal epilepsy in neonates and infants under 3 months of age: A single-center retrospective analysis.
Ma Y; Deng J; Fu Z; Chen C; Wang X; Wang X; Weng J; Shen Y; Wang X; Fang F
Epilepsy Res; 2023 Nov; 197():107240. PubMed ID: 37852019
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of oxcarbazepine active metabolite in Chinese children with epilepsy.
Li X; Wei S; Wu H; Zhang Q; Zhao Z; Mei S; Feng W; Wu Y
Eur J Pediatr; 2023 Oct; 182(10):4509-4521. PubMed ID: 37493972
[TBL] [Abstract][Full Text] [Related]
4. Uncontrolled headache induced by oxcarbazepine.
Piovesan EJ; Teive HG; de Paola L; Silvado CE; Crippa A; Amaral VC; Della Colleta MV; Di Stani F; Werneck LC
J Headache Pain; 2007 Oct; 8(5):301-5. PubMed ID: 17955169
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics of oxcarbazepine active metabolite in Chinese paediatric patients with epilepsy: Model-based dose optimization.
Wu W; Yang WS; Xu XY; Ge XL; Lu J; Wang GF; Wang Y; Li ZP
Basic Clin Pharmacol Toxicol; 2024 May; 134(5):712-726. PubMed ID: 38506371
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of oxcarbazepine 10-monohydroxy derivative in Chinese adult epileptic patients.
Yang Q; Hu Y; Zhang X; Zhang X; Dai H; Li X
Eur J Hosp Pharm; 2023 Mar; 30(e1):e90-e96. PubMed ID: 35787526
[TBL] [Abstract][Full Text] [Related]
7. The role of angiotensin receptor blockers in treating epilepsy: a review.
Shaikh TG; Hasan SFS; Ahmed H; Kazi AI; Mansoor R
Neurol Sci; 2024 Apr; 45(4):1437-1445. PubMed ID: 38079018
[TBL] [Abstract][Full Text] [Related]
8. Lesson of the month 1: To stop a fit, but swinging low.
Ogbebor O; Agrawal A; Yegneswaran B
Clin Med (Lond); 2018 Jun; 18(3):256-258. PubMed ID: 29858439
[TBL] [Abstract][Full Text] [Related]
9. Hyponatremia With Anticonvulsant Medications: A Narrative Review.
Bembenick KN; Mathew J; Heisler M; Siddaiah H; Moore P; Robinson CL; Kaye AM; Shekoohi S; Kaye AD; Varrassi G
Cureus; 2024 Apr; 16(4):e57535. PubMed ID: 38707045
[TBL] [Abstract][Full Text] [Related]
10. Ketogenic diet and cognition in neurological diseases: a systematic review.
Pavón S; Lázaro E; Martínez O; Amayra I; López-Paz JF; Caballero P; Al-Rashaida M; Luna PM; García M; Pérez M; Berrocoso S; Rodríguez AA; Pérez-Núñez P
Nutr Rev; 2021 Jun; 79(7):802-813. PubMed ID: 33354711
[TBL] [Abstract][Full Text] [Related]
11. The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An update on management of behavioral and psychological symptoms in dementia.
Chen A; Copeli F; Metzger E; Cloutier A; Osser DN
Psychiatry Res; 2021 Jan; 295():113641. PubMed ID: 33340800
[TBL] [Abstract][Full Text] [Related]
12. Unilateral thalamic lesion mimicking genetic generalized epilepsy.
Kulick-Soper CV; Stein JM; Chen IH; Ellis CA; Davis KA
Epileptic Disord; 2020 Dec; 22(6):836-838. PubMed ID: 33355534
[No Abstract] [Full Text] [Related]
13. Pharmacotherapeutic management of Parkinson's disease inpatients: how about asking hospital pharmacists?
Lertxundi Etxebarria U; Palacios-Zabalza I; Ibarrondo I; Domingo-Echaburu S; Hernandez R; Isla A; Solinis M
Eur J Hosp Pharm; 2021 Nov; 28(Suppl 2):e140-e145. PubMed ID: 33355236
[TBL] [Abstract][Full Text] [Related]
14. Geographical distribution and antibiotics susceptibility patterns of toxigenic Vibrio cholerae isolates from Kisumu County, Kenya.
Awuor SO; Omwenga EO; Daud II
Afr J Prim Health Care Fam Med; 2020 Dec; 12(1):e1-e6. PubMed ID: 33354982
[TBL] [Abstract][Full Text] [Related]
15. A Systematic Review and Meta-Analysis Considering the Risk for Congenital Heart Defects of Antidepressant Classes and Individual Antidepressants.
De Vries C; Gadzhanova S; Sykes MJ; Ward M; Roughead E
Drug Saf; 2021 Mar; 44(3):291-312. PubMed ID: 33354752
[TBL] [Abstract][Full Text] [Related]
16. Mini-Review: The MSA transcriptome.
Pérez-Soriano A; Martí MJ
Neurosci Lett; 2021 Jan; 743():135586. PubMed ID: 33352281
[TBL] [Abstract][Full Text] [Related]
17. Cannabidiol in the treatment of epilepsy: Current evidence and perspectives for further research.
Franco V; Bialer M; Perucca E
Neuropharmacology; 2021 Mar; 185():108442. PubMed ID: 33347884
[TBL] [Abstract][Full Text] [Related]
18. Comparative Remission Rates and Tolerability of Drugs for Generalised Anxiety Disorder: A Systematic Review and Network Meta-analysis of Double-Blind Randomized Controlled Trials.
Kong W; Deng H; Wan J; Zhou Y; Zhou Y; Song B; Wang X
Front Pharmacol; 2020; 11():580858. PubMed ID: 33343351
[No Abstract] [Full Text] [Related]
19. Uric Acid as a Risk Factor for Chronic Kidney Disease and Cardiovascular Disease - Japanese Guideline on the Management of Asymptomatic Hyperuricemia.
Hisatome I; Li P; Miake J; Taufiq F; Mahati E; Maharani N; Utami SB; Kuwabara M; Bahrudin U; Ninomiya H
Circ J; 2021 Jan; 85(2):130-138. PubMed ID: 33342914
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
